| Primary information |
|---|
| sequence ID | Seq_5765 |
| Peptide sequence | NRIPESGGDNSVFDIFELTGAARKGSGR |
| CancerPDF_ID | CancerPDF_ID2154, CancerPDF_ID11051, |
| PMID | 21136997,26993605 |
| Protein Name | Thrombospondin-1,Thrombospondin-1 |
| UniprotKB Entry Name | TSP1_HUMAN,TSP1_HUMAN |
| Fluid | Serum,Serum |
| M/Z | 2949.4693,2950.6 |
| Charge | 1,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,MALDI-TOF |
| Peptide Identification technique | LC-MS-MS/MS,LTQ-Orbitrap-MS/MS |
| Quantification Technique | LC-ESI-MS,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,less than 0.000001 |
| CancerPDF_ID | CancerPDF_ID2154, CancerPDF_ID11051, |
| p-Value | NA,less than 0.05 |
| Software | MASCOT(v. 2.2.01),SEQUEST |
| Length | 28,28 |
| Cancer Type | Colorectal cancer,Esophageal squamous cell carcinoma (ESCC) |
| Database | SwissProt Database,IPI Human Database (3.45) |
| Modification | NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,for training 100 ESCC patients and 98 healthy individuals were used and for validation 101 ESCC patients and 98 healthy individuals were used |
| Regulation | NA,Upregulated in patients vs normal with mean intensity 84.95 in control and 666.08 in cancer |
| Validation | Leave One out Cross validation,external cross validation done |
| Sensitivity | NA,97% on training dataset and 97.3 on validation dataset |
| Specificity | NA,95.92% on training dataset and 100% on validation dataset |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |